Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma.
Zheng Z, Wang JB, Sun R, Wang N, Weng XQ, Xu TY, Fu D, Feng Y, Xu PP, Cheng S, Wang L, Zhao Y, Qu B, Huang CX, Zhao WL.
Zheng Z, et al. Among authors: fu d.
Signal Transduct Target Ther. 2025 Jan 20;10(1):29. doi: 10.1038/s41392-024-02105-7.
Signal Transduct Target Ther. 2025.
PMID: 39828715
Free article.